Tulin H. Dadali, Ph.D.
Affiliations: | 2014 | School of Medicine and Dentistry | University of Rochester, Rochester, NY |
Area:
Cell Biology, Biochemistry, PathologyGoogle:
"Tulin Dadali"Mean distance: (not calculated yet)
Parents
Sign in to add mentorFrances Lund | grad student | 2014 | Rochester | |
(The Role of CD38 in Regulating NAD Metabolism, Oxidative Stress Responses, and Activity of NAD-Consuming Enzymes.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Dadali T, Diers AR, Kazerounian S, et al. (2021) Elevated levels of mitochondrial CoQ induce ROS-mediated apoptosis in pancreatic cancer. Scientific Reports. 11: 5749 |
Schultz MD, Dadali T, Jacques SA, et al. (2020) Inhibition of the NAD salvage pathway in schistosomes impairs metabolism, reproduction, and parasite survival. Plos Pathogens. 16: e1008539 |
Dadali T, Kulkarni S, Ng R, et al. (2018) Abstract 873: BPM 31510, a clinical stage metabolic modulator, demonstrates therapeutic efficacy in glioblastoma models of temozolomide chemo-sensitive and resistance by targeting mitochondrial function Cancer Research. 78: 873-873 |
Awate P, Dadali T, Ng R, et al. (2018) Abstract 3530: Coenzyme Q10 (BPM31510-IV in clinical trials) increases mitochondrial Q-pool and modulates electron transport chain function to elicit cell death in pancreatic cancer cells Cancer Research. 78: 3530-3530 |
Nagpal S, Dadali T, Jang T, et al. (2017) Effect of BPM31510 on radiosensitivity of temozolomide-resistant glioblastoma cell model and survival in in vivo C6 glioma rat model supporting phase I clinical investigation in GBM. Journal of Clinical Oncology. 35: e13509-e13509 |
Kazerounian S, Sarma A, Gaur N, et al. (2017) Abstract 5576: BPM 31510, a clinical stage candidate demonstrates potent anti-tumor effect in an immune-competent syngeneic pancreatic cancer model Cancer Research. 77: 5576-5576 |
Gesta S, Nagpal S, Dadali T, et al. (2017) Abstract 4067: BPM31510, a clinical stage metabolic modulator demonstrates therapeutic efficacy in anin vivoC6 rat glioma model and synergizes with temozolomide Cancer Research. 77: 4067-4067 |
Dadali T, Krumova K, Diers AR, et al. (2017) Abstract 1497: BPM31510 modulates mitochondrial complex activity to influence oxidative stress in effectuating cell death in multiple cancers Cancer Research. 77: 1497-1497 |
Botta D, Dadali T, Mousseau BJ, et al. (2016) Abstract LB-055: High-throughput screening efforts for the identification of selective and potent inhibitors of CD38 for the treatment of hematological cancers Cancer Research. 76 |
Dadali T, Diers AR, Ouro-Djobo R, et al. (2016) Abstract 212: BPM 31510 synergizes gemcitabine efficacy in pancreatic adenocarcinoma via mechanism independent of its anti-Warburg influence on metabolism Cancer Research. 76: 212-212 |